Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.13
Bid: 2.12
Ask: 2.20
Change: -0.02 (-0.92%)
Spread: 0.08 (3.774%)
Open: 2.20
High: 2.20
Low: 2.13
Prev. Close: 2.18
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

Wed, 30th Sep 2020 18:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Itaconix PLC - chemicals company - For 2019, pretax loss narrowed to USD1.4 million from USD10.1 million the year before, on revenue that grew by 46% to USD1.3 million from USD881,000, as a result of increased product demand, cost savings and new orders from customers in Europe.

----------

New Trend Lifestyle Group PLC - Singapore-based Feng Shui products maker - For first half of 2020, pretax loss widens to SGD1.4 million from SGD314,000 the year before, on revenue that fell by 38% to SGD1.9 million from SGD3.1 million, as retail outlets were closed due to lockdown restrictions.

----------

Immupharma PLC - pharmaceutical company - For the first half of 2020, pretax loss narrows to GBP3.1 million from GBP6.7 million the year before, on revenue that dropped to GBP62,207 from GBP77,925.

----------

Echo Energy PLC - Latin American-focused upstream oil and gas firm - For the first half of 2020, pretax loss narrows to USD5.7 million from USD7.9 million, on revenue that more than doubled to USD5.7 million from USD2.7 million, on production that came up to 390,844 barrels of oil equivalent.

----------

Goldstone Resources Ltd - Africa-focused gold resource developer - For the first half of 2020, pretax loss widens to USD292,098 from USD289,951 the year before, despite a fall in administrative expenses. During period, gained formal approval for ten-year mining lease on Akrokeri and Homase licences in Ghana.

----------

Quixant PLC - Cambridge-based technology outsourcer for gaming industry - For first half of 2020, swings to pretax loss of GBP3.0 million from profit of USD3.0 million the year before. On adjusted basis, pretax loss at USD1.4 million from profit of USD3.4 million, on revenue that declined to USD27.9 million from USD41.9 million. Looking ahead, expects return to profitable trading in second half of year.

----------

Aberdeen Standard European Logistics Income PLC - Investment trust - As at June 30, net asset value per share at EUR1.13 compared to EUR1.11 on December 31.

----------

Schroder UK Public Private Trust PLC - investment trust - As at June 30, net asset value per share fell 8.1% to 45.44 pence from 49.46p at the end of December 31.

----------

Trident Royalties PLC - London-based mining royalty firm - For the first half of 2020, pretax loss widens to USD1.1 million from USD138,844 the year before. Looking ahead, commodity markets have continued to strengthen in the third quarter, leading to a positive outlook for the rest of the year.

----------

Hemogenyx Pharmaceuticals PLC - pre-clinical stage biopharmaceutical firm headquartered in London - For the first half of 2020, pretax loss widens to GBP835,189 from GBP706,670 the year before due to rise in administrative costs. Keeps confident outlook due to significant progress on several development fronts, including CDX antibody research.

----------

Immotion Group PLC - immersive entertainment company headquartered in Manchester - For the first half of 2020, pretax loss remains flat at GBP2.6 million, on revenue that dropped to GBP818,000 from GBP1.3 million the year before, due to four months of trading being effectively lost to the Covid-19 lockdown.

----------

India Capital Growth Fund Ltd - investment fund - As at June 30, net asset value per share down 20% to 70.42 pence from 97.02p the same date the year before. Portfolio holds 32 investee companies, as seven holdings were sold and seven new investments were made.

----------

Chesterfield Resources PLC - copper-gold exploration and development company active in Cyprus - For the first half of 2020, pretax loss narrows to GBP257,465 from GBP303,704 the year before. Looking ahead, outlook for copper and gold is robust, as commodities rose following lockdowns.

----------

URU Metals Ltd - exploration and development - For the year to the end of March, pretax loss narrows to USD732,000 from USD2.3 million due to the absence of exceptional charges related to the impairment of group's 50% interest in the Burgersfort project and shares held in Management Resource Solutions PLC.

----------

Edenville Energy PLC - operator of the Rukwa coal project in southwest Tanzania - For 2019, pretax loss widens to GBP1.9 million from GBP1.8 million, as revenue declined to GBP233,414 from GBP337,125. The lack of capital following debt repayments in Tanzania affected the company's ability to increase production to targeted levels.

----------

ADM Energy PLC - natural resources investor with assets in Nigeria - For the first half of 2020, pretax loss widens to GBP975,000 from GBP448,000, due to no revenue being made for period, compared to GBP2.2 million the prior year. Total production from Aje field was 2,126 barrels of oil per day, down from 2,967 bopd.

----------

SEEEN PLC - London-based social media technology firm - For the first half of 2020, pretax loss widens to USD2.0 million from USD219,572 the year before on sharp rise in administrative expenses, despite generating revenue of USD3.7 million. For the third quarter, revenue improved as viewer growth accelerated.

----------

Predator Oil & Gas Holdings PLC - Jersey-based oil and gas company - For the first half of 2020, pretax loss widened to GBP784,156 from GBP512,263 the year before, as no revenue generated. Successfully executed phases one and two of Pilot Enhanced Oil Recovery onshore Trinidad using injected carbon dioxide.

----------

Solo Oil PLC - AIM-listed oil investment company - For the first half of 2020, pretax loss was GBP1.3 million, widened from GBP800,000. During period, did not proceed with acquisition of offshore Netherlands assets from ONE Dyas. Is continuing to screen acquisition opportunities.

----------

Triple Point Social Housing REIT PLC - London-based real estate investment trust - As at June 30, net asset value per share is up at 105.34 pence from 103.96p the year before. For the six month-period, annualised rental income rose to GBP28.0 million from GBP21.1 million. However, pretax profit dropped to GBP9.0 million from GBP9.9 million. Dividend per share up at 2.59 pence from 2.54p. Plans to raise GBP70 million through a placing, open offer and subscription of shares at price of 106 pence each.

----------

Open Orphan PLC - pharmaceutical services company - For the first half of 2020, pretax loss widens to GBP6.8 million from GBP1.1 million, despite generating revenue of GBP7.1 million.

----------

Provexis PLC - health food ingredient maker - For the year to the end of March, pretax loss narrows to GBP424,465 from GBP533,375, on revenue that rose by 8% to GBP347,937 from GBP322,189 the year before, through high product sales.

----------

SIMEC Atlantis Energy Ltd - London-based developer of renewable and sustainable energy projects - For the first half of 2020, pretax loss narrows to GBP6.2 million from GBP12.4 million the year before, as revenue rose sharply to GBP7.9 million from GBP2.0 million, from contributions generated by the Atlantis tidal turbine and engineering services division.

----------

Trafalgar Property Group PLC - residential homes developer based in Kent - For the year to the end of March, pretax loss narrows to GBP1.0 million from GBP2.3 million, due to a smaller writing off of assets. Revenue dipped to GBP2.0 million from GBP2.1 million, reflecting the sale of two assets, compared to five assets the prior year.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 12:52

Immupharma jumps amid new IP strategy for P140 technology platform

(Alliance News) - Immupharma PLC on Tuesday announced a new intellectual property strategy to significantly enhance the patent life and commercial value for its P140 technology platform.

Read more
25 Mar 2024 12:20

Incanthera says first order from skincare deal doubles

(Alliance News) - ImmuPharma PLC on Monday noted updates on Incanthera PLC's commercial skincare deal with Marionnaud, which was first announced in December 2023.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 10:55

AIM WINNERS & LOSERS: ImmuPharma order doubles; Aeorema swings to loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
6 Mar 2024 13:05

EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up

(Alliance News) - The following is a round-up of earnings and trading updates of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
19 Dec 2023 17:52

EARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
18 Dec 2023 12:18

IN BRIEF: Incanthera signs skincare stocking deal, raises GBP1 million

Incanthera PLC - develops technologies in dermatology and oncology - Raises GBP1.0 million in equity to support a deal that will see a major retailer stock Incanthera's 'Skin + Cell' range of skincare products. Raises GBP800,000 from the subscription to 11.4 million new shares at 7 pence each by new and existing institutional investors. At the same price, the University of Bradford converts GBP200,000 that is owed to it by Incanthera into 2.9 million new shares. The university, a founding shareholder in Incanthera, will own 11.2% of the enlarged share capital, with all the newly issued shares representing 15.5% of this. Incanthera also grants warrants to advisers to subscribe for another 800,000 new shares at the same price of 7p over the next 10 years. ImmuPharma PLC, which currently has a 12.7% stake in Incanthera, says it is "delighted" with the announcement of the skincare deal and successful fundraise.

Read more
7 Sep 2023 17:07

TRADING UPDATES: RA International loss narrows as revenue grows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
31 Aug 2023 13:05

ImmuPharma launches GBP2 million fund raise as interim loss narrows

(Alliance News) - ImmuPharma PLC on Thursday announced a share placing and a retail share offer to raise just under GBP2 million, while it also reported a narrowed loss in the first half of the year on reduced expenses.

Read more
21 Aug 2023 12:33

ImmuPharma agrees 12 month extension to Incanthera warrant instrument

(Alliance News) - Incanthera PLC and ImmuPharma PLC on Monday agreed a 12 month extension to their warrant instrument.

Read more
23 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
Friday 30 June 
Argo Blockchain PLCAGM
Ascent Resources PLCAGM
Bluejay Mining PLCAGM
Caspian Sunrise PLCAGM
Codex Acquisitions PLCAGM
Domino's Pizza Group PLCGM re directors' remuneration policy
Fenikso LtdAGM
Fiinu PLCAGM
FireAngel Safety Technology Group PLCAGM
GENinCode PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Hiro Metaverse Acquisitions I SAAGM
i3 Energy PLCGM re premium share cancellation
ImmuPharma PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kefi Gold & Copper PLCAGM
Kistos Holdings PLCAGM
KRM22 PLCAGM
Kropz PLCAGM
LoopUp Group PLCAGM
Medica Group PLCAGM
Mirriad Advertising PLCAGM
Rockfire Resources PLCAGM
Savannah Energy PLCAGM
Strip Tinning Holdings PLCAGM
ThomasLloyd Energy Impact Trust PLCAGM
URA Holdings PLCAGM
World Chess PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jun 2023 12:02

IN BRIEF: ImmuPharma to start next two phases of Lupuzor trial

ImmuPharma PLC - London-based drug discovery and development company - Will start phases two and three of the clinical trial for Lupuzor in the seocnd half of 2023, following talks with the US Food & Drug Administration. Says the clinical trial will be supported by Avion Pharmaceuticals. Adds further details of the trial will be shared at a later stage. Lupuzor, or P140, is a potential treatment for Lupus disease.

Read more
18 May 2023 12:12

IN BRIEF: ImmuPharma rises on FDA feedback for neurological disease

ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after a pre-investigational new drug meeting, which confirms the route for a Phase 2/3 adaptive clinical study of P140 in chronic idiopathic demyelinating polyneuropathy. Says the feedback recognises that P140 is suitable to be studied in another disease indication, in addition to systemic lupus erythematosus.

Read more
11 May 2023 11:48

IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced

ImmuPharma PLC - London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pretax loss narrows to GBP4.5 million from GBP8.9 million a year earlier, as operating loss reduces to GBP3.0 million from GBP6.6 million. Research and development expenditure is GBP2.0 million, down from GBP3.7 million in 2021. Chief Executive Officer Tim McCarthy says: "As a board, we remain focused on bringing our two key late stage clinical assets, Lupuzor for lupus and CIDP closer to the market."

Read more
19 Apr 2023 15:40

IN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meeting

ImmuPharma PLC - London-based drug discovery and development company - Notes the US Food & Drug Administration has set a date of June 7 for a type-C meeting to provide guidance on the phase 2/3 adaptive study of Lupuzor, or P140, in patients with systemic lupus erythematosus, a common type of immune disease lupus. Says this follows the announcement in late March, when it submitted a phase 2/3 clinical trial protocol to the US FDA testing the Lupuzor treatment for lupus patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.